These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22057099)

  • 1. A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB).
    Yim YS; Choi JS; Kim GT; Kim CH; Shin TH; Kim DG; Cheon J
    Chem Commun (Camb); 2012 Jan; 48(1):61-3. PubMed ID: 22057099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.
    Dadparvar M; Wagner S; Wien S; Kufleitner J; Worek F; von Briesen H; Kreuter J
    Toxicol Lett; 2011 Sep; 206(1):60-6. PubMed ID: 21726608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R; Cramer S; Hüwel S; Galla HJ
    Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Büchel C; Kreuter J
    J Drug Target; 2010 Dec; 18(10):842-8. PubMed ID: 20849354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
    Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
    Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
    Lu W; Tan YZ; Hu KL; Jiang XG
    Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.
    Qiao R; Jia Q; Hüwel S; Xia R; Liu T; Gao F; Galla HJ; Gao M
    ACS Nano; 2012 Apr; 6(4):3304-10. PubMed ID: 22443607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
    Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
    Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
    Lu W; Tan YZ; Jiang XG
    Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Kuo YC; Lee CL
    Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier.
    Gil ES; Wu L; Xu L; Lowe TL
    Biomacromolecules; 2012 Nov; 13(11):3533-41. PubMed ID: 23066958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle accumulation and transcytosis in brain endothelial cell layers.
    Ye D; Raghnaill MN; Bramini M; Mahon E; Åberg C; Salvati A; Dawson KA
    Nanoscale; 2013 Nov; 5(22):11153-65. PubMed ID: 24077327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.
    Pardridge WM; Mietus LJ
    J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
    Michaelis K; Hoffmann MM; Dreis S; Herbert E; Alyautdin RN; Michaelis M; Kreuter J; Langer K
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1246-53. PubMed ID: 16554356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
    Kuo YC; Yu HW
    Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
    Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
    Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.